Search

everythinglearnresearchcommunity

for

Search:↓

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Scientists found key proteins and genes that affect skin and hair health, and identified potential new treatments for hair loss, skin disorders, and wound healing.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Traditional Chinese medicines with heavy metals can cause severe poisoning.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Effective treatments for severe alopecia areata are still lacking.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Scalp microbiota changes may be linked to inflammation in Alopecia Areata.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

COVID-19 may cause hair loss due to infection stress or treatments.

Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Telogen effluvium causes temporary hair loss, but new hair still grows.

Different causes of hair loss require specific treatments, and most men and women will experience some form of hair thinning as they age.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.